Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DIPHENYLGUANIDINE: 14 Adverse Event Reports & Safety Profile

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain
14
Total FAERS Reports
6 (42.9%)
Deaths Reported
12
Hospitalizations
14
As Primary/Secondary Suspect
4
Life-Threatening

First Report: 20191029 · Latest Report: 20201001

What Are the Most Common DIPHENYLGUANIDINE Side Effects?

#1 Most Reported
Pulmonary pain
14 reports (100.0%)
#2 Most Reported
Lower respiratory tract infection
14 reports (100.0%)
#3 Most Reported
Arthropathy
14 reports (100.0%)

All DIPHENYLGUANIDINE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Arthropathy 14 100.0% 6 12
Lower respiratory tract infection 14 100.0% 6 12
Pulmonary pain 14 100.0% 6 12
Product dose omission issue 13 92.9% 6 11
Abdominal discomfort 12 85.7% 6 10
Knee arthroplasty 12 85.7% 6 10
Rash 12 85.7% 6 10
Drug abuse 11 78.6% 5 10
Intentional product misuse 11 78.6% 5 10
Off label use 11 78.6% 6 9
Overdose 10 71.4% 5 9
Amyloid arthropathy 6 42.9% 0 6
Condition aggravated 6 42.9% 6 4
Covid-19 6 42.9% 6 4
Inflammation 6 42.9% 6 4
Lung neoplasm malignant 6 42.9% 6 4
Obesity 6 42.9% 0 6
Radiation inflammation 6 42.9% 6 4
Schizophrenia 6 42.9% 6 4

Who Reports DIPHENYLGUANIDINE Side Effects? Age & Gender Data

Gender: 63.6% female, 36.4% male. Average age: 63.6 years. Most reports from: GB. View detailed demographics →

Is DIPHENYLGUANIDINE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2019 1 0 1
2020 10 6 8

View full timeline →

What Is DIPHENYLGUANIDINE Used For?

IndicationReports
Depression 11
Abdominal discomfort 9
Product used for unknown indication 6

Official FDA Label for DIPHENYLGUANIDINE

Official prescribing information from the FDA-approved drug label.